Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Headhunter shareholders approved the redomiciliation

3/27/24 HEAD

ZIL reported for 2023 by RAS

3/27/24 ZILL

SPB Exchange to focus on IPOs of companies under sanctions

3/27/24 SPBE

Lenzoloto reported for 2023 by RAS

3/27/24 LNZL

Belon reported for 2023 according by RAS

3/27/24 BLNG

Moscow Exchange expands the range of OTC share market instruments

3/27/24 MOEX

Whoosh reported for 2023 by RAS

3/27/24 WUSH

IVA Technologies plans to IPO by the end of the year

3/27/24 IVAT

Inter RAO's exports in Q1 will amount to about 2.1 bln kWh

3/27/24 IRAO

Tinkoff launched Tinkoff Leasing service

3/27/24 T